Not just an ophthalmology-focused CRO, Iris Pharma helps clients around the world navigate every stage of the drug and device development process and delivers customized solutions for: 

•	Assessing possible therapeutic effect in ocular diseases
•	Adding value to promising drug candidates or medical devices
•	Designing development plans and preclinical packages and carrying out studies to proceed with confidence from bench to bedside
•	Providing the comprehensive clinical development services you need, from First-in-Human through Phase IV and Post-marketing follow-through

We accompany start-up companies, biotechnology companies, large pharmaceutical companies, pharmaceutical labs, universities, research organizations and consultants in their ophthalmology projects.

Our assets: 
•	32 years of experience in the field of ophthalmology research
•	All ophthalmic indications mastered
•	70+ FDA, PMDA & EMA new ocular drug approvals and ophthalmic medical device marketing authorizations
•	State-of-the-art medical and scientific equipment
•	Highly specialized and qualified staff
•	Statement of compliance with GLP and GCLP
•	Adherence to all trial-related requirements (ICH-GCP)
•	French research tax credit accreditation (CIR)

IRIS PHARMA

Org chart

Teams

Offices